ESR1 and breast carcinoma: Further research on an enriched guajadial fraction obtained from the P. guajava leaf extract demonstrates that its tumor inhibitory activity may have been through the estrogen receptors, similar to tamoxifen, as guajadial is structurally similar to this breast cancer drug.